{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:00:17Z","timestamp":1761580817513},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ygyno.2010.08.032","type":"journal-article","created":{"date-parts":[[2010,9,27]],"date-time":"2010-09-27T13:41:25Z","timestamp":1285594885000},"page":"436-443","source":"Crossref","is-referenced-by-count":30,"title":["Distribution of human papillomavirus 58 and 52 E6\/E7 variants in cervical neoplasia in Chinese women"],"prefix":"10.1016","volume":"119","author":[{"given":"Tian","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.08.032_bb0005","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/JVI.71.3.2463-2472.1997","article-title":"Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective","volume":"71","author":"Yamada","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<203::AID-IJC9>3.0.CO;2-9","article-title":"Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer","volume":"82","author":"Nindl","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH809>3.0.CO;2-C","article-title":"Human papillomavirus variants and squamous neoplasia of the cervix","volume":"193","author":"Giannoudis","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0020","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/sj.bjc.6603450","article-title":"Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study","volume":"95","author":"Li","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<408::AID-IJC6>3.0.CO;2-#","article-title":"Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women","volume":"70","author":"Huang","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0035","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<775::AID-IJC27>3.0.CO;2-3","article-title":"Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women","volume":"73","author":"Liaw","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/(SICI)1097-0215(19980130)75:3<484::AID-IJC25>3.0.CO;2-7","article-title":"Human papillomavirus types 52 and 58","volume":"75","author":"Lin","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0045","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1349-7006.2009.01161.x","article-title":"Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer","volume":"100","author":"Onuki","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/bjc.1989.236","article-title":"Natural history of cervical neoplasia: consistent results obtained by an identification technique","volume":"60","author":"Gustafsson","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ijc.2910610305","article-title":"The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36months","volume":"61","author":"Remmink","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0065","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/1055-9965.EPI-05-0864","article-title":"Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant","volume":"15","author":"Grodzki","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2010.08.032_bb0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1590\/S0100-879X2006000600002","article-title":"Epidemiological and functional implications of molecular variants of human papillomavirus","volume":"39","author":"Sichero","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0075","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1128\/JVI.69.12.7743-7753.1995","article-title":"Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments","volume":"69","author":"Yamada","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0080","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ijc.1520","article-title":"Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes","volume":"94","author":"Zehbe","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3","article-title":"Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities","volume":"69","author":"Londesborough","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0090","first-page":"829","article-title":"Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype","volume":"58","author":"Zehbe","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0095","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","article-title":"Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins","volume":"98","author":"Narisawa-Saito","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0198-8859(03)00033-8","article-title":"Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women","volume":"64","author":"Zehbe","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ygyno.2005.12.002","article-title":"Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population","volume":"102","author":"Lizano","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0110","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ijc.22481","article-title":"High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18","volume":"120","author":"Sichero","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1525-1438.2007.00968.x","article-title":"Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China","volume":"18","author":"Hong","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0120","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1128\/JCM.02483-07","article-title":"Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination","volume":"46","author":"Grisaru","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0125","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1128\/JCM.43.7.3260-3266.2005","article-title":"Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia","volume":"43","author":"Soderlund-Strand","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0130","doi-asserted-by":"crossref","unstructured":"Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24 Suppl 3: S3\/1\u201310.","DOI":"10.1016\/j.vaccine.2006.05.115"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens: Part B. Biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1743-422X-7-66","article-title":"Prevalence and risk profile of cervical human papillomavirus infection in Zhejiang Province, southeast China: a population-based study","volume":"7","author":"Ye","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0145","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4014\/jmb.0812.679","article-title":"Distribution of human papillomavirus type 58 variants in progression of cervical dysplasia in Korean women","volume":"19","author":"Bae","year":"2009","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ijc.1520","article-title":"Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes","volume":"94","author":"Zehbe","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jnci\/djj297","article-title":"Human papillomavirus type 16 and 18 variants: race-related distribution and persistence","volume":"98","author":"Xi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0160","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/jnci\/94.16.1249","article-title":"Association of human papillomavirus type 58 variant with the risk of cervical cancer","volume":"94","author":"Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(01)00570-5","article-title":"Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia\/cervical cancer in relation to their oncogenic potential","volume":"170","author":"Xin","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0170","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1099\/vir.0.008227-0","article-title":"Profile of physical status and gene variation of human papillomavirus 58 genome in cervical cancer","volume":"90","author":"Wu","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0175","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(05)61263-9","article-title":"Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms","volume":"352","author":"Zehbe","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0180","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1073\/pnas.88.12.5187","article-title":"Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16","volume":"88","author":"Firzlaff","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ygyno.2010.08.032_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/j.1460-2075.1990.tb08091.x","article-title":"The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation","volume":"9","author":"Barbosa","year":"1990","journal-title":"EMBO J"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810006359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810006359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T05:15:04Z","timestamp":1591938904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810006359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0090825810006359"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.08.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}